INKT – mink therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MiNK Therapeutics, Inc. (NASDAQ: INKT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
MiNK Reports First Quarter 2024 Results [Yahoo! Finance]
MiNK Reports First Quarter 2024 Results
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer [Yahoo! Finance]
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
Form 8-K MiNK Therapeutics, Inc. For: May 14
Form 10-Q MiNK Therapeutics, Inc. For: Mar 31
Form ARS MiNK Therapeutics, Inc. For: Dec 31
Form DEF 14A MiNK Therapeutics, Inc. For: Dec 31
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.